InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Milne Jill C.. Director active across 1 company, notably Biocryst Pharmaceuticals INC. In total, 3 filings have been recorded. History available since 23 January 2026. The latest transaction was disclosed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations